glp-1 therapies success rate Q&A: Long-term of hinges on more than just a prescription Weight maintenance after discontinuation of

Saxenda 3 mg daily for weight management): Proven efficacy with 5-8% weight reduction and cardiovascular outcome benefits in the LEADER trial Dulaglutide (Trulicity 0.75-4.5 mg weekly): Convenient once-weekly dosing with demonstrated cardiovascular benefit in the REWIND trial Tirzepatide (Mounjaro for diabetes

GLP-treatment could start to become highly personalized: As Horn put it to me, somebody with obstructive sleep apnea may still want to take Zepbound because that drug has proven effective for both that condition and weight loss at the same time

Association between exenatide use and incidence of Alzheimers disease

Lilly plans to debut the pill at $149 for a months supply of the lowest dose, and refills will then be available for $299 within the next 45 days

Supporting your body during the entire weight loss journey The bigger picture extends beyond hair

W., Hviid, A., Eliasson, B., Hveem, K., Melbye, M., Gudbjrnsdottir, S., Ueda, P., & the Nordic GLP-1RA Thyroid Cancer Collaboration